MINI01.03: Phase (Ph) I Study of the Safety and Efficacy of the cMET Inhibitor Capmatinib (INC280) in Patients with Advanced cMET+ NSCLC

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2016-11, Vol.11 (11), p.S257-S258
Main Authors: Bauer, Todd M., Schuler, Martin, Berardi, Rossana, Lim, Wan-Teck, Van Geel, Robin, De Jonge, Maja, Azaro, Analia, Gottfried, Maya, Han, Ji-Youn, Lee, Dae Ho, Wollner, Mira, Hong, David, Vogel, Arndt, Delmonte, Angelo, Krohn, Alexander, Zhang, Yong, Squires, Matthew, Giovannini, Monica, Akimov, Mikhail, Kim, Dong-Wan
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
DOI:10.1016/j.jtho.2016.09.018